Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (2), 319-329
- https://doi.org/10.1046/j.1523-1747.2001.01248.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in PsoriasisJournal of Investigative Dermatology, 1999
- Treatment of Psoriasis with Interleukin-10Journal of Investigative Dermatology, 1998
- A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.The Journal of Experimental Medicine, 1996
- 20 MHz sonography, colorimetry and image analysis in the evaluation of psoriasis vulgarisJournal of Dermatological Science, 1995
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995
- lnterleukin-8 Induces HLA-DR Expression on Cultured Human Keratinocytes via Specific ReceptorsInternational Archives of Allergy and Immunology, 1995
- Keratinocyte Interleukin-10 Expression Is Upregulated in Tape-Stripped Skin, Poison Ivy Dermatitis, and Sezary Syndrome, but Not in Psoriatic PlaquesClinical Immunology and Immunopathology, 1994
- Activated keratinocytes present bacterial-derived superantigens to T lymphocytes: relevance to psoriasisJournal of Dermatological Science, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Psoriasis of early and late onset: Characterization of two types of psoriasis vulgarisJournal of the American Academy of Dermatology, 1985